innoscripta SE (ISIN: DE000A40QVM8) has reported a robust performance for the first half of 2026, with revenue increasing by 43% year-on-year to EUR 63.1 million. Adjusted EBIT rose by 49% to EUR 36.4 million, reflecting the company's continued growth momentum. The adjusted EBIT margin reached 57.7%, underscoring operational efficiency.
The company attributes this growth to the German R&D tax allowance (Forschungszulage), which remains a key driver. The number of innoscripta customers increased to more than 2,900 during the period. Central to this success is Clusterix, the company's scalable software platform for managing research and development activities. In the first half of 2026, innoscripta strengthened Clusterix as its central infrastructure for project structuring, data management, and application submissions. This enhancement enables automated data validation, higher data quality, and faster, more standardized processes, while establishing consistent workflows across different markets. This technological foundation is critical for the company's international scaling efforts.
Geographic expansion has progressed as planned. innoscripta opened its first office in France near Toulouse and has already secured customers. The UK market entry commenced with a location in Manchester as of July 1, 2026. In the US, the company has begun serving its first clients in this high-growth market. The flexibility of Clusterix in adapting to different regulatory requirements has facilitated efficient entry into new markets.
Commenting on the results, the Management Board confirmed its guidance for the full year 2026. Assuming consistent timing of submission and approval of customers' applications, the company expects Group revenue of at least EUR 140 million and EBIT of at least EUR 80 million. Detailed financial figures are available in the Half-Year Report on the company's website in the Investors section.
innoscripta will host a virtual earnings call on its H1 2026 results today at 3:00 p.m. CEST. The invitation and dial-in link are available on the company's website under Investor Events.
These results demonstrate innoscripta's successful execution of its growth strategy, driven by the increasing demand for R&D tax incentives and the scalability of its software platform. The company's international expansion positions it well to capture opportunities in key markets, further solidifying its competitive standing.
